ONCO Stock Price Chart
ONCO Financial
Onconetix Inc
$0.38
-5.1%
$-0.02
At close: May 13, 16:00:00 GMT-4
$0.38
-0.51%
$0
Post-market: May 13, 20:00:00 GMT-4
Back
Onconetix Inc (ONCO) Financial
Key Stats
Prev.Close
$0.4078
Open
$0.4078
Day's Range
$0.38 - $0.4078
52 week range
$0.385 - $74.3
Volume
616.3K
Avg.Volume
5.1M
Dividend yield
--
EPS (TTM)
-74.35
Market Cap
$265.6K
What is ONCO?
Onconetix, Inc. is a commercial stage biotechnology company, which engages in the research, development and commercialization of proprietary therapeutics, diagnostics and services for clinicians and patients for oncology. The company is headquartered in Cincinnati, Ohio. The company went IPO on 2022-02-18. The firm owns Proclarix, an in vitro diagnostic test for prostate cancer approved for sale in the European Union under the In Vitro Diagnostic Regulation. Proclarix is an easy-to-use next generation protein-based blood test that can be done with the same sample as a patient’s regular Prostate-Specific Antigen (PSA) test.
